General Information of Drug (ID: DMCJXWK)

Drug Name
URMC-099 Drug Info
Synonyms compound 1 [PMID 24044867]
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
54764565
TTD Drug ID
DMCJXWK

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cyclin-dependent kinase-like 2 (CDKL2) TTMO45N CDKL2_HUMAN Inhibitor [1]
Death-associated protein kinase 3 (DAPK3) TTERVQN DAPK3_HUMAN Inhibitor [1]
Fms-like tyrosine kinase 3 (FLT-3) TTGJCWZ FLT3_HUMAN Inhibitor [1]
Leucine-rich repeat kinase 2 (LRRK2) TTK0FEA LRRK2_HUMAN Inhibitor [1]
MAPK/ERK kinase kinase 2 (MAP3K2) TTK1N5G M3K2_HUMAN Inhibitor [1]
Mixed lineage kinase 1 (MAP3K9) TTUNSIX M3K9_HUMAN Inhibitor [1]
Mixed lineage kinase 2 (MAP3K10) TT9FN4J M3K10_HUMAN Inhibitor [1]
Mixed lineage kinase 3 (MAP3K11) TTETX6Q M3K11_HUMAN Inhibitor [1]
SRSF protein kinase 2 (SRPK2) TTCZEJ9 SRPK2_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Mixed lineage kinase 1 (MAP3K9) DTT MAP3K9 5.869 5.671 5.501 6.322
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Fms-like tyrosine kinase 3 (FLT-3) DTT FLT3 2.11E-01 -0.05 -0.16
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. J Med Chem. 2013 Oct 24;56(20):8032-48.